Skip to content

DERMAX: what changed

BE 0667.730.677NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€517,589
2024 · €2.6m-€2.1m
Equity
€5.3m
2024 · €4.8m+€517,589
Cash
€168,229
2024 · €257,494-€89,265
Balance sheet total
€5.7m
2024 · €6.6m-€823,874

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€858,897

    down €858,897 (-23.7%), from €3.6m to €2.8m

    of which Trade receivables: -€1.7m

  • Cash -€89,265

    down €89,265 (-34.7%), from €257,494 to €168,229

    mainly Trade debts (-€1.2m) and Investment in fixed assets (net) (-€308,788)

  • Receivables after one year +€78,649

    new in 2025: €78,649

Equity and liabilities
  • Trade debts -€1.2m

    down €1.2m (-73.6%), from €1.6m to €414,335

  • Profit (loss) carried forward +€517,589

    up €517,589 (+35.3%), from €1.5m to €2.0m

  • Accrued charges and deferred income -€149,810

    no longer reported in 2025 (was €149,810)

Income statement
  • Gross operating margin -€2.1m

    down €2.1m (-63.6%), from €3.3m to €1.2m

  • Turnover +€1.6m

    new in 2025: €1.6m

  • Purchases and services +€810,536

    up €810,536 (+16,246%), from €4,989 to €815,525

  • Taxes +€295,445

    up €295,445 (+297%), from €99,633 to €395,078

  • Depreciation -€174,480

    down €174,480 (-39.9%), from €437,629 to €263,149

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €2.6m
Gross operating margin -€2.1m
Depreciation +€174,480
Other operating charges +€34
Financial income -€14,321
Financial charges +€122,472
Taxes -€295,445
Result 2025 €517,589
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€219,523
Investment -€308,788
Financing €0
Cash 2024 €257,494
Net result for the year +€517,589
Depreciation +€263,149
Receivables after one year -€78,649
Receivables within one year +€858,897
Trade debts -€1.2m
Tax, wage and social debts -€36,066
Accrued charges and deferred income -€149,810
Investment in fixed assets (net) -€308,788
Cash 2025 €168,229
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €6,550,807 €5,726,933 -€823,874 -12.6%
Fixed assets 21/28 €2,665,712 €2,711,351 +€45,639 +1.7%
Intangible fixed assets 21 €2,665,712 €2,711,351 +€45,639 +1.7%
Current assets 29/58 €3,885,095 €3,015,582 -€869,513 -22.4%
Amounts receivable after more than one year 29 - €78,649 +€78,649
Other amounts receivable 291 - €78,649 +€78,649
Amounts receivable within one year 40/41 €3,627,601 €2,768,704 -€858,897 -23.7%
Trade receivables 40 €3,184,837 €1,477,025 -€1.7m -53.6%
Other amounts receivable 41 €442,764 €1,291,679 +€848,915 +192%
Cash at bank and in hand 54/58 €257,494 €168,229 -€89,265 -34.7%
Total equity and liabilities 10/49 €6,550,807 €5,726,933 -€823,874 -12.6%
Equity 10/15 €4,795,009 €5,312,598 +€517,589 +10.8%
Contributions 10/11 €3,250,022 €3,250,022 = 0.0%
Capital 10 €2,183,505 €2,183,505 = 0.0%
Issued capital 100 €2,183,505 €2,183,505 = 0.0%
Contributions outside capital 11 €1,066,517 €1,066,517 = 0.0%
Share premium 1100/10 €1,066,517 €1,066,517 = 0.0%
Reserves 13 €77,249 €77,249 = 0.0%
Non-distributable reserves 130/1 €77,249 €77,249 = 0.0%
Legal reserve 130 €77,249 €77,249 = 0.0%
Profit (loss) carried forward 14 €1,467,738 €1,985,327 +€517,589 +35.3%
Amounts payable 17/49 €1,755,798 €414,335 -€1.3m -76.4%
Amounts payable within one year 42/48 €1,605,988 €414,335 -€1.2m -74.2%
Trade debts 44 €1,569,922 €414,335 -€1.2m -73.6%
Suppliers 440/4 €1,569,922 €414,335 -€1.2m -73.6%
Taxes, remuneration and social security 45 €36,066 - -€36,066
Taxes 450/3 €36,066 - -€36,066
Accrued charges and deferred income 492/3 €149,810 - -€149,810
Turnover 70 - €1,554,264 +€1.6m
Goods, raw materials, services and sundry goods 60/61 €4,989 €815,525 +€810,536 +16,246%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €437,629 €263,149 -€174,480 -39.9%
Other operating charges 640/8 €1,473 €1,439 -€34 -2.3%
Gross operating margin 9900 €3,302,198 €1,202,474 -€2.1m -63.6%
Operating profit (loss) 9901 €2,863,096 €937,886 -€1.9m -67.2%
Financial income 75/76B €45,668 €31,347 -€14,321 -31.4%
Recurring financial income 75 €45,668 €31,347 -€14,321 -31.4%
Financial charges 65/66B €179,038 €56,566 -€122,472 -68.4%
Recurring financial charges 65 €179,038 €56,566 -€122,472 -68.4%
Profit (loss) for the period before taxes 9903 €2,729,726 €912,667 -€1.8m -66.6%
Income taxes 67/77 €99,633 €395,078 +€295,445 +297%
Profit (loss) for the period 9904 €2,630,093 €517,589 -€2.1m -80.3%
Profit (loss) for the period to be appropriated 9905 €2,630,093 €517,589 -€2.1m -80.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€4.9m to €6.4m

Midpoint €5.5m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €2.6m
Capitalised earnings €7.3m to €10.2m
Indication €4.9m to €6.4m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€5,312,598
Intangible fixed assets (21)
-€2,711,351
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€2.6m

Capitalised earnings

net result for the year (9904)
2025
€517,589
2024
€2,630,093
2023
€116,681
excluding non-recurring income and charges
-€90,870
2022
€276,823
2021
-€194,917
Average result, excluding non-recurring income and charges
€1,018,937
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€7.3m / €8.5m / €10.2m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.